Other

Granted (in shares)

HCA Healthcare Granted (in shares) remained flat by 0.0% to $82.45 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $76.36 to $82.45. Over 4 years (FY 2021 to FY 2025), Granted (in shares) shows an upward trend with a 17.2% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ4 2025Feb 10, 2026

How to read this metric

Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.

Detailed definition

This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...

Peer comparison

Standard disclosure for companies with active equity compensation programs.

Metric ID: other_share_based_compensation_arrangements_by_share_bas_099e66

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$174.98$236.00$253.49$305.44$329.80
YoY Change+34.9%+7.4%+20.5%+8.0%
Range$174.98$329.80
CAGR+17.2%
Avg YoY Growth+17.7%
Median YoY Growth+14.2%
Current Streak4+ years growth

Frequently Asked Questions

What is HCA Healthcare's granted (in shares)?
HCA Healthcare (HCA) reported granted (in shares) of $82.45 in Q4 2025.
How has HCA Healthcare's granted (in shares) changed year-over-year?
HCA Healthcare's granted (in shares) increased by 8.0% year-over-year, from $76.36 to $82.45.
What is the long-term trend for HCA Healthcare's granted (in shares)?
Over 4 years (2021 to 2025), HCA Healthcare's granted (in shares) has grown at a 17.2% compound annual growth rate (CAGR), from $174.98 to $329.80.
What does granted (in shares) mean?
The total number of shares issued or granted under specific equity compensation plans.